Nuvation Bio (NUVB) Shares Issued (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Shares Issued of $85.1 million for Q1 2026, up 9.88% year-over-year from $77.4 million in Q1 2025, and up 15.05% quarter-over-quarter from $74.0 million in Q4 2025.
Nuvation Bio (NUVB) Shares Issued (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Shares Issued for 7 consecutive years, with $85.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 9.88% year-over-year to $85.1 million; the TTM figure through Mar 2026 stood at $85.1 million (up 9.88% YoY), while the FY2025 annual figure was $74.0 million, up 37.46% from the prior year.
- Shares Issued improved to $85.1 million in Q1 2026 per NUVB's latest filing, from $74.0 million in the prior quarter.
- Across five years, Shares Issued topped out at $85.1 million in Q1 2026 and bottomed at $3.1 million in Q1 2023.
- Historically, Shares Issued has averaged $33.7 million across 5 years, with a median of $23.4 million in 2022.
- Annual changes were most pronounced in 2022 — Shares Issued soared 1375.46% — and 2023, when it tumbled 84.34%.
- Nuvation Bio's Shares Issued stood at $4.3 million in 2022, then surged by 530.22% to $26.8 million in 2023, then surged by 100.52% to $53.8 million in 2024, then surged by 37.46% to $74.0 million in 2025, then climbed by 15.05% to $85.1 million in 2026.
- Business Quant data shows NUVB's Shares Issued at $85.1 million in Q1 2026, $74.0 million in Q4 2025, and $32.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 81.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.61 Mn |
| Jun 30, 2026 | 81.61 Mn |
| Mar 31, 2026 | 85.09 Mn |
| Mar 31, 2026 | 85.09 Mn |
| Dec 31, 2025 | 73.96 Mn |
| Dec 31, 2025 | 73.96 Mn |
| Sep 30, 2025 | 32.30 Mn |
| Sep 30, 2025 | 32.30 Mn |
| Jun 30, 2025 | 77.65 Mn |
| Jun 30, 2025 | 77.65 Mn |
| Mar 31, 2025 | 77.44 Mn |
| Mar 31, 2025 | 77.44 Mn |
| Dec 31, 2024 | 53.81 Mn |
| Dec 31, 2024 | 53.81 Mn |
| Sep 30, 2024 | 23.26 Mn |
| Sep 30, 2024 | 23.26 Mn |
| Jun 30, 2024 | 23.91 Mn |
| Jun 30, 2024 | 23.91 Mn |
| Mar 31, 2024 | 11.88 Mn |
| Mar 31, 2024 | 11.88 Mn |